ArticleCanadian family physician Medecin de famille canadien2015
Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians.
Article in Canadian family physician Medecin de famille canadien, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.BMC public health · 2023Article
- Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.Health expectations : an international journal of public participation in health care and health policy · 2022Article
- Stakeholders' Perceptions of Factors Influencing the Use of Take-Home-Naloxone.Pharmacy (Basel, Switzerland) · 2020Review
- Article
- Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017Article
- Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.Journal of general internal medicine · 2017Article
- Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.BMC research notes · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore family physicians' attitudes toward prescribing naloxone to at-risk opioid users, as well as to determine the opportunities and challenges for expanding naloxone access to patients in family practice settings.
designOne-hour focus group session and SWOT (strengths, weaknesses, opportunities, and threats) analysis.
settingWorkshop held at the 2012 Family Medicine Forum in Toronto, Ont.
participantsSeventeen conference attendees from 3 Canadian cities who practised in various family practice settings and who agreed to participate in the workshop.
methodsThe workshop included an overview of information about naloxone distribution and overdose education programs, followed by group discussion in smaller focus groups. Participants were instructed to focus their discussion on the question, "Could this [overdose education and naloxone prescription] work in your practice?" and to record notes using a standardized discussion guide based on a SWOT analysis. Two investigators reviewed the forms, extracting themes using an open coding process. MAIN
findingsSome participants believed that naloxone could be used safely among family practice patients, that the intervention fit well with their clinical practice settings, and that its use in family practice could enhance engagement with at-risk individuals and create an opportunity to educate patients, providers, and the public about overdose. Participants also indicated that the current guidelines and support systems for prescribing or administering naloxone were inadequate, that medicolegal uncertainties existed for those who prescribed or administered naloxone, and that high-quality evidence about the intervention's effectiveness in family practice was lacking.
conclusionFamily physicians believe that overdose education and naloxone prescription might provide patients at risk of opioid overdose in their practices with broad access to a potentially lifesaving intervention. However, they explain that there are key barriers currently limiting widespread implementation of naloxone use in family practice settings.
Identifiers
30207979PMC4463897W2260392056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.